Tobias Rothe
Erlangen, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Pregnancies in Patients with Autoimmune Disease Receiving CAR T-Cell Therapy.
Journal: The New England journal of medicine
Published: July 29, 2026
Hormone levels of female patients with SLE after anti-CD19 CAR T-cell treatment do not indicate a signal of impaired ovarian reserve.
Journal: Rheumatology (Oxford, England)
Published: April 22, 2026
Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.
Journal: Annals of the rheumatic diseases
Published: December 19, 2025
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease.
Journal: The New England journal of medicine
Published: October 15, 2025
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.
Journal: Nature medicine
Published: September 30, 2025
BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease.
Journal: The New England journal of medicine
Published: September 04, 2024
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series.
Journal: The Lancet. Rheumatology
Published: May 07, 2024
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.
Journal: The New England journal of medicine
Published: February 21, 2024
Bispecific T cell engager therapy for refractory rheumatoid arthritis.
Journal: Nature medicine
Published: December 13, 2023
The Joint-Brain Axis: Insights From Rheumatoid Arthritis on the Crosstalk Between Chronic Peripheral Inflammation and the Brain.
Journal: Frontiers in immunology
Published: September 30, 2020
IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation.
Journal: Immunity
Published: May 24, 2020
Last Updated: 09/26/2026